China Universal Asset Management Company’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
52,527
+11,407
| +28% | +$26.4K | 0.01% | 347 |
|
|
2025
Q1 | $57.2K | Sell |
41,120
-2,336
| -5% | -$3.25K | 0.01% | 410 |
|
|
2024
Q4 | $75.2K | Buy |
43,456
+4,039
| +10% | +$6.99K | 0.01% | 419 |
|
|
2024
Q3 | $79.2K | Buy |
39,417
+17,446
| +79% | +$35.1K | 0.01% | 370 |
|
|
2024
Q2 | $49.2K | Sell |
21,971
-13,937
| -39% | -$31.2K | 0.01% | 357 |
|
|
2024
Q1 | $103K | Buy |
35,908
+14,286
| +66% | +$41K | 0.01% | 369 |
|
|
2023
Q4 | $38.3K | Buy |
+21,622
| New | +$38.3K | 0.01% | 392 |
|
|
2022
Q4 | – | Sell |
-385
| Closed | -$1K | – | 468 |
|
|
2022
Q3 | $1K | Buy |
+385
| New | +$1K | ﹤0.01% | 418 |
|